临床外科杂志 ›› 2018, Vol. 26 ›› Issue (11): 835-838.doi: 10.3969/j.issn.10056483.2018.11.011

• • 上一篇    下一篇

FOXM1及E钙黏蛋白在乳腺癌组织中的表达及其临床意义的研究

  

  1. 215002  江苏苏州,南京医科大学附属苏州医院/苏州市立医院普通外科(马也、陈建华、周大胜),放疗科(胡群超、顾科) 
  • 收稿日期:2018-05-30 出版日期:2018-11-20 发布日期:2018-12-03
  • 通讯作者: 周大胜,Email:zhoudszck@163.com
  • 基金资助:
    江苏省青年医学重点人才资助项目(QNRC2016233)

The study of the expression and clinical significance of FOXM1 and Ecadherin in breast cancer

  1. Department of General Surgery,Nanjing Medical University,the Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Suzhou,215002,China
  • Received:2018-05-30 Online:2018-11-20 Published:2018-12-03

摘要: 目的    探讨乳腺癌病人根治性术后癌组织、非癌细胞浸润组织中FOXM1和E钙黏蛋白的表达及与病理参数的关系和临床意义。方法  免疫组织化学方法(IHC)检测术后乳腺癌及非癌细胞浸润组织中FOXM1和E钙黏蛋白的表达,利用SPSS软件分析其与临床病理特征的关系。结果 68例乳腺浸润性导管癌组织中,FOXM1蛋白的阳性表达率为48.5%(33/68),E钙黏蛋白的阳性表达率为41.2%(28/68)。肿瘤组织中FOXM1蛋白的表达高于非癌细胞浸润组织。FOXM1和E钙黏蛋白的阳性表达与病人年龄、部位、组织学分型、分子分型均无关。FOXM1在腋窝淋巴结转移组中其阳性表达率高于无淋巴结转移组(P<0.05),并与肿瘤大小、肿瘤TNM分期、雌激素受体状态相关(P<0.05),E钙黏蛋白的表达率降低与淋巴结转、肿瘤TNM分期密切相关(P<0.05)。FOXM1和E钙黏蛋白的表达呈负相关(r=-0.324,P<0.05)。结论  FOXM1和E钙黏蛋白是乳腺癌浸润、转移的重要的生物学标记物。

关键词: 乳腺癌, 叉头蛋白转录因子, E钙黏蛋白, 组织芯片

Abstract:   Objective    To investigate the expression of FOXM1 and Ecadherin in breast cancer tissues and their relationship with clinicopathological parameters.Methods  The expression of FOXM1 and Ecadherin in breast cancer and surrounding normal tissues were detected by immunohistochemical method(IHC).Then we analyzed the data with the SPSS statistical software.Results  The positive rate of FOXM1 protein was 48.5%(33/68)in 68 cases of invasive ductal carcinoma of breast,and the positive rate of Ecadherin protein was 41.2%(28/68).The expression of FOXM1 protein in tumor tissues was higher than that in normal breast tissues.The expression of FOXM1 and Ecadherin was unrelated with age,location,histological grading and molecular typing.The expression rate of FOXM1 in axillary lymph node metastasis group was higher than that in nonlymph node metastasis group(P<0.05),and correlated with tumor size tumor TNM staging and estrogen receptor status(P<0.05).The expression of Ecadherin protein was also correlated with lymph node metastasis and tumor TNM staging(P<0.05).The expression of FOXM1 and Ecadherin protein was negatively correlated(r=-0.324,P<0.05). Conclusion  FOXM1 and Ecadherin are important biomarkers of breast cancer.

Key words: breast cancer,  ,  , FOXM1, 〓 Ecadherin, tissue microarray

[1] 赵英杰 张荷焕. 甲状腺癌合并乳腺癌一例[J]. 临床外科杂志, 2018, 26(9): 719-719.
[2] 喻希 高磊 谢森 伍依依 潘铁军. 原发性肾上腺淋巴瘤一例[J]. 临床外科杂志, 2018, 26(11): 890-890.
[3] 昝晓晨 孙圣荣 陈创等 . Ki-67在HER-2阳性乳腺浸润性导管癌中的表达和意义 [J]. 临床外科杂志, 2013, 21(2): 119-122.
[4] 王宁 刘金彪 王新征等. 乳腺癌患者静脉血栓形成危险因素的临床研究[J]. 临床外科杂志, 2013, 21(1): 20-22.
[5] 常贵建;王烈. 人乳头瘤病毒与乳腺癌关系的研究进展[J]. 临床外科杂志, 2012, 20(8): 589-591.
[6] 崔乐 方金鸣 王平. 乳腺癌内乳淋巴结的临床研究[J]. 临床外科杂志, 2012, 20(5): 347-347.
[7] 于永政 赵宁 赵辉. 中心静脉导管对乳腺癌改良根治术后皮下积液引流的疗效观察[J]. 临床外科杂志, 2012, 20(5): 369-369.
[8] 张彦收 焦俊琴 卞晓丽 曹淼 王学良 刘运江. 可吸收止血海绵在乳腺癌改良根治术中应用的疗效观察[J]. 临床外科杂志, 2012, 20(4): 250-250.
[9] 王立军 唐蔚 朱珊 万金男 魏文 孙圣荣. 乳腺癌合并2型糖尿病患者的临床特征分析[J]. 临床外科杂志, 2012, 20(4): 252-252.
[10] 杨荣华;虞敏晶;张桂普等. 乳腺癌术后辅助化疗常规骨髓支持治疗的临床分析[J]. 临床外科杂志, 2012, 20(12): 853-855.
[11] 邓宏武 周征宇 万能斌等. TAC与TC新辅助化疗方案治疗局部晚期乳腺癌疗效比较 [J]. 临床外科杂志, 2012, 20(11): 770-772.
[12] 单东力 杨学伟 . mTOR信号通路及其靶向药物在乳腺癌中的进展 [J]. 临床外科杂志, 2012, 20(11): 819-822.
[13] 胡玮 丁宇 李良 . 雌激素硫酸转移酶与乳腺癌发病的研究现状 [J]. 临床外科杂志, 2012, 20(11): 823-824.
[14] 张应天. 乳腺癌治疗之新观念[J]. 临床外科杂志, 2012, 20(1): 18-18.
[15] 沈国双. 乳腺癌保乳手术32例临床分析[J]. 临床外科杂志, 2011, 19(8): 581-581.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!